Ceftriaxone, sold under the brand name Rocephin, is a third-generation cephalosporin antibiotic used for the treatment of a number of bacterial infections. From Wikipedia
Ceftriaxone-resistant and extensively drug-resistant strains are increasing, with 17 cases reported since January 2024, raising concerns about potential treatment challenges.
